Innoviva (INVA) Minority Interest (2017 - 2021)
Innoviva's (INVA) quarterly Minority Interest came in at $111.2 million in Q4 2021, up 63.7% YoY from $67.9 million in Q4 2020, and up 24.94% on a QoQ basis from $89.0 million in Q3 2021.
Analysis
Innoviva (INVA) Minority Interest (2017 - 2021) Analysis & Trends
Innoviva (INVA) has 5 years of Minority Interest data on file, last reported at $111.2 million in Q4 2021.
- Quarterly Minority Interest rose 63.7% year-over-year to $111.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $111.2 million (up 63.7% YoY) and the FY2021 annual result came in at $111.2 million, up 63.7% from the prior year.
- Minority Interest improved to $111.2 million in Q4 2021, from $89.0 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $111.2 million in Q4 2021 to a low of $152000.0 in Q4 2017.
- A 5-year average of $35.0 million and a median of $26.3 million in 2020 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2018 — Minority Interest jumped 3498.03% — and 2021, when it surged 63.7%.
- Tracing INVA's Minority Interest over 5 years: stood at $152000.0 in 2017, then jumped by 3498.03% to $5.5 million in 2018, then jumped by 423.33% to $28.6 million in 2019, then jumped by 137.33% to $67.9 million in 2020, then surged by 63.7% to $111.2 million in 2021.
- The last three Minority Interest figures came in at $111.2 million (Q4 2021), $89.0 million (Q3 2021), and $64.0 million (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Innoviva | 1.56 Bn | 984.81 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 111.19 Mn |
| Sep 30, 2021 | 88.99 Mn |
| Jun 30, 2021 | 63.97 Mn |
| Mar 31, 2021 | 62.22 Mn |
| Dec 31, 2020 | 67.93 Mn |
| Sep 30, 2020 | 49.32 Mn |
| Jun 30, 2020 | 35.91 Mn |
| Mar 31, 2020 | 26.33 Mn |
| Dec 31, 2019 | 28.62 Mn |
| Sep 30, 2019 | 16.71 Mn |
| Jun 30, 2019 | 20.02 Mn |
| Mar 31, 2019 | 11.70 Mn |
| Dec 31, 2018 | 5.47 Mn |
| Sep 30, 2018 | 3.08 Mn |
| Jun 30, 2018 | 1.99 Mn |
| Mar 31, 2018 | 811,000.00 |
| Dec 31, 2017 | 152,000.00 |